Sofinnova Partners

Venture Capital · Biotechnology
Has an LEI2 legal entitiesSponsors visas
Lately:3 news stories in 90 daysFollow changes →

Facts

as of Nov 18, 2026

Sofinnova Partners is a life sciences venture capital firm investing in innovation worldwide. It backs companies in biopharma, medical technology, digital medicine and industrial biotechnology, from early-stage company creation through later-stage crossover rounds. Founded in 1972, it is one of the oldest venture capital firms in Europe and is headquartered in Paris, France, with a team spanning several European countries.

Legal name
Sofinnova Partners SASactive
Headquarters
Paris, France
Founded
1972
Employees
50–99French register · Dec 2023
Revenue
$45.4M2023 · French register (413388596)
Legal entities
2 in 1 countries
Register numbers
SIREN 413388596

These are the key facts about Sofinnova Partners on Alion as of Nov 18, 2026. Sofinnova Partners is headquartered in Paris, France. It was founded in 1972.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
Sofinnova Partners SAS · annuaire-entreprises.data.gouv.fr ↗
Yes
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Named in the work visa registers of United Kingdom.

A-ratedSponsor licence
Skilled WorkerVisa route
0Open roles in United Kingdom

In the register as Sofinnova Partners UK Ltd, London

Other sponsors in the same field
Alert me
UK Home Office · checked Nov 18, 2026 · the register ↗

Footprint

Hiring in 3 cities in 3 countries.

3Cities
3Countries
Loading the map
SiteTypeOpen rolesHires most forEngineering
Paris FranceHeadquarters0
London United KingdomRegional office0
Milan ItalyRegional office0
Source: office addresses in postings and company registers

Financials

Revenue and money on record.

$45.4MRevenue2023
Sources: funding announcements, grant and company registers

Money

Sofinnova Partners: 5 money records, each linked to its source.

StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money out
Stake or loan in another company · Ingenix
Jun 2026 · Seed
not statedPaid
Stake or loan in another company · Alia therapeutics
Apr 2023 · Seed
$4.8MPaid
Stake or loan in another company · GFBiochemicals
May 2022 · Series A
$16.2MPaid
Stake or loan in another company · EnginZyme
Apr 2020 · Series A
$6.9MPaid
Stake or loan in another company · Pi-Cardia
Apr 2020 · Venture round
$27MPaid
Taxes
No public tax figures for this company or its entities.
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

Owners & entities

Sofinnova Partners operates through 2 legal entities in 1 countries.

Legal entities2 in 1 countries
operator · FR SIREN 413388596
FR
related · FR SIREN 791644883
FR
Stakes and purchases
Stake or loan in another company · Ingenix
Jun 2026 · Seed
not stated
Stake or loan in another company · Alia therapeutics
Apr 2023 · Seed
$4.8M
Stake or loan in another company · GFBiochemicals
May 2022 · Series A
$16.2M
Stake or loan in another company · EnginZyme
Apr 2020 · Series A
$6.9M
Stake or loan in another company · Pi-Cardia
Apr 2020 · Venture round
$27M
Holders and shares as each register or filing states them.

Newsroom

top 2%Web presenceof 133.2M domains by links, Common Crawl
Nov 162026
News · Tech Funding News
European life sciences companies are moving from clinical validation to commercialisation, and the funds backing them are growing.…
Sep 282026
News · EU-Startups
Sofinnova Partners, a Paris-based life sciences investor, has closed its Sofinnova MD Start IV fund at €82 million. The firm said the fund was oversubscribed and will build on a…
Sep 282026
News · Tech.eu
European life sciences venture capital firmSofinnova Partners has closed its fourth medtech fund, Sofinnova MD Start IV,at €82 million. The oversubscribed fund will expand Sofinn…
Sources: the outlets named on each headline, each story once